S. Schück

发表

Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group.

A. Destée, H. Petit, H. Allain, 2000, European neurology.

Our experience with ischial pressure sores in a series of 34 patients

S. Schück, E. Watier, A. Pardo, 2000, European Journal of Plastic Surgery.

Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers

J. Gandon, H. Allain, D. Kleinermans, 2002, Fundamental & clinical pharmacology.

Exacerbation of juvenile myoclonic epilepsy with lamotrigine.

A. Biraben, G. Edan, J. Scarabin, 2000, Neurology.

Aminotransferase Levels and Silymarin in de novo Tacrine-Treated Patients with Alzheimer’s Disease

P. Brissot, J. Gandon, H. Allain, 1999, Dementia and Geriatric Cognitive Disorders.

Experimental and clinical methods in the development of anti‐Alzheimer drugs

H. Allain, D. Bentué‐Ferrer, J. Reymann, 1998, Fundamental & clinical pharmacology.

Efficacy and Safety of Zolpidem Administered ‘As Needed’ in Primary Insomnia

H. Allain, S. Schück, L. Arbus, 2001 .

Procedural Memory in Recent-Onset Parkinson’s Disease

H. Allain, H. Allain, V. Thomas-Ollivier, 1999, Dementia and Geriatric Cognitive Disorders.

Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting

M. Baulac, A. Brunon, P. Plouin, 2007, Seizure.

Five-Year Follow-Up of Early Lisuride and Levodopa Combination Therapy versus Levodopa Monotherapy in de novo Parkinson’s Disease

A. Destée, H. Petit, H. Allain, 2000, European Neurology.

Comparative effects of pharmacotherapy on the maintenance of cognitive function

H. Allain, N. Mauduit, S. Schück, 2001, European Psychiatry.

[Rating scales and questionnaires in Parkinson's disease].

H. Allain, J. Chaperon, N. Mauduit, 2000, Revue neurologique.